140 related articles for article (PubMed ID: 11010680)
1. No known cause: leukemia research.
Tecnologica; 2000; ():1, 3-6, 14. PubMed ID: 11010680
[No Abstract] [Full Text] [Related]
2. [Changing concept of conventional therapy in chronic myelogenous leukemia].
Ueda R
Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
[No Abstract] [Full Text] [Related]
3. [Monitoring of Ph chromosome by fluorescence in situ hybridization in chronic myeloid leukemia].
Takahashi N; Miura I
Rinsho Ketsueki; 2000 Apr; 41(4):272-4. PubMed ID: 10846453
[No Abstract] [Full Text] [Related]
4. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
5. [Treatment strategies for chronic myeloid leukemia].
Jinnai I
Rinsho Ketsueki; 2005 Jan; 46(1):1-6. PubMed ID: 16708910
[No Abstract] [Full Text] [Related]
6. Chronic myelogenous leukemia clinical practice guidelines in oncology.
O'Brien S;
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S14-28. PubMed ID: 19795573
[No Abstract] [Full Text] [Related]
7. [Imatinib therapy for patients with chronic myelogenous leukemia].
Usui N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):297-303. PubMed ID: 15791812
[TBL] [Abstract][Full Text] [Related]
8. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
[TBL] [Abstract][Full Text] [Related]
9. Unsuccessful allogeneic and autologous transplants after prolonged interferon-alpha treatment in a pediatric patient with chronic myeloid leukemia.
Pérez-Caballero C; Maldonado MS; Tamariz R; de Oteyza JP; Muñoz A
Haematologica; 2000 Jan; 85(1):105-6. PubMed ID: 10629605
[No Abstract] [Full Text] [Related]
10. Autografting for CML--overview and perspectives.
Goldman JM
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S71-4. PubMed ID: 8769708
[No Abstract] [Full Text] [Related]
11. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
Carella AM
Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645
[No Abstract] [Full Text] [Related]
12. [Recent progress in therapy for chronic myelogenous leukemia].
Urabe A
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
[TBL] [Abstract][Full Text] [Related]
13. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
Petukhov VI; Strozha IL; Bondare DK
Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
[No Abstract] [Full Text] [Related]
14. [Chronic myeloid leukemia--treatment].
Stoetzer OJ; Hentrich M; Salat C
Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
[No Abstract] [Full Text] [Related]
15. Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemia.
Meloni G; Capria S; Vignetti M; Alimena G; de Fabritiis P; Montefusco E; Mandelli F
Haematologica; 2001 Jun; 86(6):596-601. PubMed ID: 11418368
[TBL] [Abstract][Full Text] [Related]
16. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
[TBL] [Abstract][Full Text] [Related]
17. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
[TBL] [Abstract][Full Text] [Related]
19. Update on therapy for chronic myelogenous leukemia.
Weinberger BB
J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
[TBL] [Abstract][Full Text] [Related]
20. Recent advancements in the treatment of chronic myelogenous leukemia.
O'Dwyer ME; Mauro MJ; Druker BJ
Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
